Clinical Trial Update: Rituximab Combined With Chemotherapy in Burkitt's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab in combination with chemotherapy for Burkitt lymphoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia, Burkitt's Lymphoma | Phase 2 | Status: COMPLETED